National collaborations and international partnerships represent a cornerstone in our strategy and as such a number of academic, governmental and industrial partnerships have been established to ensure the setup of a robust and high standard clinical trials infrastructure and operating model. We have succeeded in establishing more than 140 collaborative agreements and partnerships with national and international pharmaceutical industrial major players as well as academic institutions including but not limited to the following.
STAKEHOLDERS
KEY PARTNERS